A study of aspirin resistance in type 2 diabetes.
J Indian Med Assoc
;
2008 Nov; 106(11): 720, 722-3, 740
Article
Dans Anglais
| IMSEAR
| ID: sea-99640
ABSTRACT
Aspirin is currently known to give inadequate protection against coronary artery disease in diabetes compared to person without it. We evaluated 97 consecutive patients with type 2 diabetes for assessing laboratory aspirin resistance and attempted to assess the impact of various clinical and biochemical parameters on it. Thirty-eight patients (39.1%) were found to be less sensitive to the action of aspirin, 7 persons (7.2%) were found to be resistant and 31 persons (31.9%) were aspirin semi-responders. Only total cholesterol, LDL-cholesterol and triglyceride had statistically significant impact on aspirin resistance (p<0.05). Three persons out of 9 with some form of macrovascular disease had aspirin resistance.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Tests fonctionnels plaquettaires
/
Triglycéride
/
Maladie des artères coronaires
/
Humains
/
Résistance aux substances
/
Antiagrégants plaquettaires
/
Agrégation plaquettaire
/
Acide acétylsalicylique
/
Facteurs de risque
/
Diabète de type 2
Type d'étude:
Etude d'étiologie
/
Facteurs de risque
langue:
Anglais
Texte intégral:
J Indian Med Assoc
Année:
2008
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS